Germany
France
Spain
United Kingdom
Turkey
Italy
Hungary
Romania
South Africa
Switzerland
USA
Canada
Mexico
Brasil
China
India
Indonesia
Japan
South Korea
Thailand
About ElringKlinger
Facts & Figures
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Order Situation | |||||||||||
| Order intake | € million | 1,690.5 | 1,874.1 | 1,977.5 | 1,483.1 | 1,737.2 | 1,735.3 | 1,732.0 | 1,693.7 | 1,615.3 | 1,418.6 |
| Order backlog | € million | 1,305.2 | 1,461.9 | 1,386.2 | 1,033.1 | 1,030.3 | 1,020.1 | 1,000.6 | 932.5 | 796.2 | 688.2 |
| Sales/Earnings | |||||||||||
| Sales revenue | € million | 1,847.1 | 1,798.4 | 1,624.4 | 1,480.4 | 1,727.0 | 1,699.0 | 1,664.0 | 1,557.4 | 1,507.3 | 1,325.8 |
| Cost of sales | € million | 1,444.3 | 1,459.9 | 1,273.4 | 1,195.5 | 1,401.7 | 1,328.9 | 1,255.6 | 1,161.5 | 1,133.0 | 967.4 |
| Gross profit margin | 21.8% | 18.8% | 21.6% | 19.2% | 18.8% | 21.8% | 24.5% | 25.4% | 24.8% | 27.0% | |
| EBITDA | € million | 200.3 | 174.2 | 216.1 | 181.5 | 181.0 | 196.6 | 238.4 | 231.2 | 222.8 | 233.4 |
| EBIT adjusted1 | € million | 100.1 | 68.4 | 102.0 | 27.7 | 61.2 | 96.2 | 137.3 | 135.6 | 135.2 | 154.0 |
| EBIT margin (adjusted)1 | 5.4% | 3.8% | 6.3% | 1.9% | 3.5% | 5.7% | 8.3% | 8.7% | 9.0% | 11.6% | |
| Earnings before taxes | € million | 53.2 | -56.1 | 100.8 | -13.6 | 41.7 | 81.4 | 110.1 | 124.1 | 128.8 | 153.1 |
| Net income | € million | 33.5 | -90.7 | 54.6 | -40.0 | 5.0 | 47.9 | 73.8 | 82.6 | 95.8 | 110.6 |
| Net income attributable to shareholders of ElringKlinger AG | € million | 39.3 | -89.1 | 55.7 | -40.8 | 4.1 | 43.8 | 69.9 | 78.6 | 91.6 | 105.7 |
| Cash flow | |||||||||||
| Net cash from operating activities | € million | 129.7 | 101.3 | 156.1 | 217.8 | 277.6 | 91.6 | 95.5 | 175.7 | 123.3 | 149.9 |
| Net cash from investing activities | € million | -90.2 | -95.5 | -73.0 | -60.6 | -84.5 | -120.7 | -193.2 | -189.7 | -212.7 | -168.0 |
| Net cash from financing activities | € million | -39.7 | 5.0 | -106.8 | -155.8 | -103.8 | 30.0 | 109.3 | 4.5 | 65.3 | 20.1 |
| Operating free cash flow2 | € million | 36.7 | 14.8 | 72.0 | 164.7 | 175.8 | -86.2 | -66.6 | -3.8 | -65.2 | -12.4 |
| Balance sheet | |||||||||||
| Balance sheet total | € million | 2,008.2 | 2,046.6 | 2,090.0 | 1,963.1 | 2,146.5 | 2,079.7 | 2,022.4 | 1,878.2 | 1,765.8 | 1,558.8 |
| Equity | € million | 910.7 | 896.9 | 982.3 | 812.8 | 891.2 | 890.1 | 889.7 | 886.4 | 855.7 | 775.2 |
| Equity ratio | 45.3% | 43.8% | 47.0% | 41,4% | 41.5% | 42.8% | 44.0% | 47.2% | 48.5% | 49.7% | |
| Net financial debt3 | € million | 323.2 | 364.2 | 369.2 | 458.8 | 595.3 | 723.5 | 655.3 | 538.8 | 486.8 | 348.3 |
| Net debt-to-EBITDA ratio4 | 1.6 | 2.1 | 1.7 | 2.5 | 3.3 | 3.7 | 2.7 | 2.3 | 2.2 | 1.5 | |
| Returns | |||||||||||
| Return on equity after taxes | 3.7% | -9.7% | 6.1% | -4.7% | 0.6% | 5.4% | 8.3% | 9.5% | 11.7% | 15.0% | |
| Return on total assets after taxes | 2.9% | -3.7% | 3.1% | -1.2% | 1.2% | 3.1% | 4.5% | 5.3% | 6.5% | 8.2% | |
| Return on Capital Employed (ROCE) | 5.6% | -2.7% | 6.4% | 1.7% | 3.4% | 5.5% | 8.2% | 8.7% | 9.5% | 12.4% | |
| R&D ratio5 | 5.2% | 5.1% | 5.1% | 5.1% | 4.7% | 5.1% | 4.6% | 4.8% | 4.7% | 5.0% | |
| Human Resources | |||||||||||
| Employees (as at Dec. 31) | 9,576 | 9,540 | 9,462 | 9,724 | 10,393 | 10,429 | 9,611 | 8,591 | 7,912 | 7,255 | |
| Stock | |||||||||||
| Earnings per share | € | 0.62 | -1.41 | 0.88 | -0.64 | 0.06 | 0.69 | 1.10 | 1.24 | 1.45 | 1.67 |
| Dividends paid | € million | 9.56 | 9.5 | 9.5 | 0.0 | 0.0 | 0.0 | 31.7 | 31.7 | 34.8 | 34.8 |
| Dividend per share | € | 0.156 | 0.15 | 0.15 | 0.00 | 0.00 | 0.00 | 0.50 | 0.50 | 0.55 | 0.55 |
1 ElringKlinger has been reporting adjusted EBIT and the adjusted EBIT margin since 2023; the previous year's figure for 2022 was calculated using the same system; financial years 2017 to 2021 shown without adjustment items
2 Net cash from operating activities and net cash from investing activities (excluding cash flows from acquisitions/divestments and financial assets)
3 Current and non-current financial liabilites less cash and less short-term securities
4 Net debt/EBITDA
5 Research and development cost (incl. capitalized development cost) in relation to group sales
6 Proposal to the Annual General Meeting on 16 May 2024
Available for download:
Group structure
History